Despite Fast-paced Momentum, SunOpta (STKL) Is Still a Bargain Stock

SunOpta (STKL), a natural and organic food company, has been identified by Zacks' 'Fast-Paced Momentum at a Bargain' screen as a compelling investment opportunity. The stock demonstrates robust momentum, including an 8.9% gain over the past 12 weeks and a beta of 1.32, coupled with a Zacks Rank #2 (Buy) driven by upward earnings estimate revisions. Crucially, STKL maintains an attractive valuation, trading at a Price-to-Sales ratio of 0.97x, suggesting significant upside potential despite its recent performance.

Analysis

SunOpta (STKL) has been identified as a compelling investment opportunity based on a combination of strong price momentum and an attractive valuation. The natural and organic food company's stock has demonstrated sustained investor interest, evidenced by an 8.9% price increase over the last 12 weeks. This momentum is characterized as 'fast-paced' by a beta of 1.32, indicating the stock's tendency to move 32% more than the broader market. Crucially, this price performance is not occurring in a vacuum; it is supported by improving fundamentals, as reflected by a Zacks Rank #2 (Buy) status, which is attributed to an upward trend in earnings estimate revisions from covering analysts. Despite these positive momentum indicators, the stock appears undervalued on a relative basis, trading at a Price-to-Sales (P/S) ratio of 0.97. This low P/S multiple suggests that the stock's valuation has not yet fully priced in its growth potential, presenting a 'bargain' scenario for a momentum-driven equity.

Key Decisions for Investors

• Investors seeking growth at a reasonable price may find STKL attractive, as the combination of positive price momentum, upward earnings revisions, and a sub-1.0x Price-to-Sales ratio supports a bullish outlook.
• Given the stock's beta of 1.32, positions should be managed with an awareness of heightened volatility; the stock is likely to outperform in a bull market but could see amplified losses in a market downturn.
• It is critical to monitor for continued upward earnings estimate revisions, as this is the primary fundamental catalyst cited as justifying the stock's momentum and 'Buy' rating.